1123211-65-3: Clindamycin Palmitate Sulfoxide

Status: In-stock

It is one of impurity present in Clindamycin, Clindamycin is a semi-synthetic lincosamide antibiotic, that inhibits bacterial protein synthesis by binding to 23S RNA of the 50S subunit of the bacterial ribosome. It impedes both the assembly of the ribosome and the translation process. The molecular mechanism through which this occurs is thought to be due to clindamycin’s three-dimensional structure. clindamycin impairs peptide chain initiation and stimulates the dissociation of peptidyl-tRNA from bacterial ribosomes. which is used to treat serious infections caused by susceptible anaerobic, streptococcal, staphylococcal, and pneumococcal bacteria.

Additional information on CAS 1123211-65-3

Catalogue No. VE009576
CAS No. 1123211-65-3
Molecular Formula C34H63ClN2O7S
Molecular Weight 679.4 g/mol
Parent drug Clindamycin
IUPAC Name 7-Chloro-1, 6, 7, 8-tetradeoxy-6-[[[(2S, 4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-(methylsulfinyl)-L-threo-?-D-galacto-Octopyranose 2-Hexadecanoate
Synonyms N/A
References Smieja, M. (1998). Current Indications for the Use of Clindamycin: A Critical Review. Canadian Journal of Infectious Diseases, 9(1), 22–28. https://doi.org/10.1155/1998/538090
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

1123211-65-3: Clindamycin Palmitate Sulfoxide

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.